Psoriasis laboratory findings: Difference between revisions

Jump to navigation Jump to search
Allisontu (talk | contribs)
Skazmi (talk | contribs)
Line 8: Line 8:
==Laboratory Findings==
==Laboratory Findings==


=== Biopsy<ref name="pmid18251745">{{cite journal |vauthors=Werner B, Bresch M, Brenner FM, Lima HC |title=Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin |journal=J. Cutan. Pathol. |volume=35 |issue=3 |pages=302–10 |year=2008 |pmid=18251745 |doi=10.1111/j.1600-0560.2007.00800.x |url=}}</ref> ===
=== Biopsy ===
On [[H&E stain|Hemotoxylin and Eosin (H&E)]] stain the following findings may be observed:
On [[H&E stain|Hemotoxylin and Eosin (H&E)]] stain the following findings may be observed:<ref name="pmid18251745">{{cite journal |vauthors=Werner B, Bresch M, Brenner FM, Lima HC |title=Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin |journal=J. Cutan. Pathol. |volume=35 |issue=3 |pages=302–10 |year=2008 |pmid=18251745 |doi=10.1111/j.1600-0560.2007.00800.x |url=}}</ref>
* Perivascular and [[dermal]] [[Inflammatory cells|inflammatory cell]] infiltration
* Perivascular and [[dermal]] [[Inflammatory cells|inflammatory cell]] infiltration
* [[Vascular]] dilation
* [[Vascular]] dilation
Line 22: Line 22:
* [[Basal cell layer]] is expanded
* [[Basal cell layer]] is expanded


=== Enzyme linked immunosorbent assay (ELISA)<ref name="pmid16865225">{{cite journal |vauthors=Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G |title=Long pentraxin 3: a marker of inflammation in untreated psoriatic patients |journal=Int. J. Mol. Med. |volume=18 |issue=3 |pages=415–23 |year=2006 |pmid=16865225 |doi= |url=}}</ref> ===
=== Enzyme linked immunosorbent assay (ELISA) ===
* In patients with severe psoriasis, increased levels of Long Pentraxin 3 protein (PTX3) are found in [[plasma]] and in [[monocytic]] cultures by [[Enzyme linked immunosorbent assay (ELISA)|enzyme linked immunosorbent assay]] (ELISA)
* In patients with severe psoriasis, increased levels of Long Pentraxin 3 protein (PTX3) are found in [[plasma]] and in [[monocytic]] cultures by [[Enzyme linked immunosorbent assay (ELISA)|enzyme linked immunosorbent assay]] (ELISA)<ref name="pmid16865225">{{cite journal |vauthors=Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G |title=Long pentraxin 3: a marker of inflammation in untreated psoriatic patients |journal=Int. J. Mol. Med. |volume=18 |issue=3 |pages=415–23 |year=2006 |pmid=16865225 |doi= |url=}}</ref>


=== Serum complement levels<ref name="pmid6159678">{{cite journal |vauthors=Vinje O, Møller P, Mellbye OJ |title=Laboratory findings in patients with psoriasis, with special reference to immunological parameters, associations with arthropathy and sacro-iliitis |journal=Scand. J. Rheumatol. |volume=9 |issue=2 |pages=97–105 |year=1980 |pmid=6159678 |doi= |url=}}</ref> ===
=== Serum complement levels ===
The following abnormalities may be observed in [[Complement|serum complement]] levels in psoriasis:<ref name="pmid6159678">{{cite journal |vauthors=Vinje O, Møller P, Mellbye OJ |title=Laboratory findings in patients with psoriasis, with special reference to immunological parameters, associations with arthropathy and sacro-iliitis |journal=Scand. J. Rheumatol. |volume=9 |issue=2 |pages=97–105 |year=1980 |pmid=6159678 |doi= |url=}}</ref>  
* Increased serum [[Immunoglobulin A|IgA]]
* Increased serum [[Immunoglobulin A|IgA]]
* Increased [[C3 (complement)|C3]] in phalyngeal [[arthropathy]] associated with psoriasis
* Increased [[C3 (complement)|C3]] in phalyngeal [[arthropathy]] associated with psoriasis

Revision as of 00:20, 1 August 2017

Psoriasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Psoriasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT scan

MRI

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Psoriasis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Psoriasis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Psoriasis laboratory findings

CDC on Psoriasis laboratory findings

Psoriasis laboratory findings in the news

Blogs on Psoriasis laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Psoriasis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Laboratory findings consistent with the diagnosis of psoriasis include parakeratosis, vascular dilation, spongiform pustules of Kogoj and Munro's microabscesses on hemotoxylin and Eosin staining of an affected area of skin. ELISA may show increased levels of Long Pentraxin 3 protein (PTX3). Complement levels may be increased.

Laboratory Findings

Biopsy

On Hemotoxylin and Eosin (H&E) stain the following findings may be observed:[1]

Enzyme linked immunosorbent assay (ELISA)

Serum complement levels

The following abnormalities may be observed in serum complement levels in psoriasis:[3]

  • Increased serum IgA
  • Increased C3 in phalyngeal arthropathy associated with psoriasis
  • Increased C4
  • Increased C3PA concentrations
  • Increased CRP concentration in sacroiliitis associated with psoriasis

References

  1. Werner B, Bresch M, Brenner FM, Lima HC (2008). "Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin". J. Cutan. Pathol. 35 (3): 302–10. doi:10.1111/j.1600-0560.2007.00800.x. PMID 18251745.
  2. Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G (2006). "Long pentraxin 3: a marker of inflammation in untreated psoriatic patients". Int. J. Mol. Med. 18 (3): 415–23. PMID 16865225.
  3. Vinje O, Møller P, Mellbye OJ (1980). "Laboratory findings in patients with psoriasis, with special reference to immunological parameters, associations with arthropathy and sacro-iliitis". Scand. J. Rheumatol. 9 (2): 97–105. PMID 6159678.

Template:WH Template:WS